Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 776-778

  Catanoso, M G ^a   Spaggiari, L ^a   Magnani, L ^a   Pipitone, N ^a   Versari, A ^a   Boiardi, L ^a   Pazzola, G ^a   Pattacini, P ^a   Salvarani, C ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Idiopathic retroperitoneal fibrosis; Infliximab

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ABDOMINAL SCINTISCANNING; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC RETROPERITONEAL FIBROSIS; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; PRIORITY JOURNAL; RELAPSE; RETROPERITONEAL FIBROSIS; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; DRUG RESISTANCE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROPERITONEAL FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84870261334     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. VAGLIO A, SALVARANI C, BUZIO C: retroperitineal fibrosis. Lancet 2006;241-51.
2. MILLER DV, MALESZEWSKI JJ: The pathology of large-vessel vasculitides. Clin Exp Rheumatol 2011;29(Suppl. 64):S92-8.
3. VAGLIO A, PIPITONE N, SALVARANI C: Chronic periaortitis: a large-vessel vasculitis? Cult Opin Rheumatol 2001;23:1-6.
4. KARDAR AH, KATTAN S, LINDSTEDT E, HANASH K: Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 2002;168:550-5.
5. VAN BOMMEL EF, SIEMES C, HAK LE, VAN der VEER SJ, HENDRIKSZ TR: Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 2007;49:615-25.
6. FRY AC, SINGH S, GUNDA SS et al:. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 2008;108:213-20.
7. MARCOLONGO R, TAVOLINI IM, LAVEDER F et al:. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004;116:194-7.
8. WARNATZ K, KESKIN AG, UHL M et al:. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 2005;64:828-33.
9. BINDER M, UHL M, WIECH T et al:. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis 2012;71:311-2.
10. SCHEEL PJ JR, FEELEY N, SOZIO SM: Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med 2011;154:31-6.
11. WALTER MA, MELZER RA, SCHINDLER C, MÜLLER-BRAND J, TYNDALL A, NITZSCHE EU: The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32:674-81.
12. PIPITONE N, VERSARI A, VAGLIO A, SALVARANI C: Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol 2011;29(Suppl. 64):S72-8.
13. MOLLOY ES, LANGFORD CA, CLARK TM, GOTA CE, HOFFMAN GS: Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008;67:1567-9.
14. BEJERANO C, BLANCO R, GONZÁLEZ-VELA C, AGÜERO R, CARRIL JM, GONZÁLEZ-GAY MA: Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab. Clin Exp Rheumatol 2012;30(Suppl. 70):S94-7
15. SALVARANI C, PIPITONE N, VERSARI A et al:. Positron emission tomography (PET): evaluation of chronic periaortitis Arthritis Rheum 2005;53:298-303.
16. VAGLIO A, GRECO P, VERSARI A et al:. Posttreatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar"? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005;23:231-4.
17. JANSEN I, HENDRIKSZ TR, HAN SH, HUISKES AW, VAN BOMMEL EF: (18) F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med 2010;21:216-21.